Linfomas
GLUN
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (26)
2022
2020
-
Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document
Bone Marrow Transplantation, Vol. 55, Núm. 4, pp. 811-817
2019
-
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
British Journal of Haematology, Vol. 184, Núm. 5, pp. 797-807
-
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Cancer Medicine, Vol. 8, Núm. 16, pp. 6955-6966
2018
2013
-
First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group
Haematologica, Vol. 98, Núm. 10, pp. 1563-1570
2009
-
Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis
Oncogene, Vol. 28, Núm. 17, pp. 1892-1903
2008
-
Nutritional recommendations in hematopoietic stem cell transplantation
Nutrition, Vol. 24, Núm. 7-8, pp. 769-775
2006
-
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma: Results of a Spanish prospective cooperative protocol
Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 2, pp. 172-183
2005
-
BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells
Cancer Research, Vol. 65, Núm. 8, pp. 3264-3272
2004
-
Biología de la leucemia linfática crónica B
Hematologia - Citocinas, Inmunoterapia y Terapia Celular
2003
-
Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study
Leukemia, Vol. 17, Núm. 10, pp. 2016-2024
-
Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation
British Journal of Haematology, Vol. 120, Núm. 3, pp. 500-504
-
Nuevas tecnologías y su significado diagnóstico en los linfomas. Versión definitiva. Microarrays de ADN
Hematologia - Citocinas, Inmunoterapia y Terapia Celular
-
Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: Association with clinical characteristics and outcome
Annals of Oncology, Vol. 14, Núm. 3, pp. 467-474
2002
-
De la citogenética al estudio con microarrays en los linfomas
Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 1, pp. 81-82
-
Enfermedad medular linfoproliferativa crónica B rica en linfocitos T
Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 1, pp. 1-4
-
NH2-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer
Clinical Cancer Research, Vol. 8, Núm. 2, pp. 347-353
2001
-
Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features
Hematology Journal, Vol. 2, Núm. 4, pp. 234-241
-
Novel genomic imbalances in b-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics
American Journal of Pathology, Vol. 158, Núm. 5, pp. 1843-1850